Skip to main content
SpringerLink
Log in

Genetic variation in the human hepatic cytochrome P-450 system

  • Special Article
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Adesnik M, Atchison M (1986) Genes for cytochrome P-450 and their regulation. CRC Crit Rev Biochem 19: 247–305

    Google Scholar 

  2. Amsbaugh SC, Ding J-H, Swan DC, Popescu NC, Chen YT (1986) Expression and chromosomal localization of the cytochrome P1-450 gene in human mitogen-stimulated lymphocytes. Cancer Res 46: 2423–2427

    Google Scholar 

  3. Asmal AC, Marble A (1984) Oral hypoglycaemic agents: An update. Drugs 28: 62–78

    Google Scholar 

  4. Ayesh R, Idle JR (1985) Evaluation of drug oxidation phenotypes in the biochemical epidemiology of lung cancer risk. In: Boobis AR, Caldwell J, De Matteis F, Elcombe CR (eds) Microsomes and drug oxidations. Taylor and Francis, London, pp 340–346

    Google Scholar 

  5. Barbeau A, Roy M, Paris S, Cloutier T, Plasse L, Poirier J (1985) Ecogenetics of Parkinson's disease: 4-Hydroxylation of debrisoquine. Lancet 2 [S466]: 1213–1216

    Google Scholar 

  6. Black SD, Coon MJ (1986) Comparative structures of P-450 cytochromes. In: Ortiz de Montellano PR (ed) Cytochrome P-450; structure, mechanism, and biochemistry. Plenum Press, New York London

    Google Scholar 

  7. Brøsen K, Otton SV, Gram LF (1985) Sparteine oxidation polymorphism in denmark. Acta Pharmacol Toxicol 57: 357–360

    Google Scholar 

  8. Eichelbaum M, Baur MP, Dengler HJ, Osikowska-Evers BO, Tieves G, Zekorn C, Rittner C (1986) The gene controlling polymorphic sparteine oxidation is localized on chromosome 22 in close linkage to P1 blood group. Abstract 42 III rd CP T Stockholm

  9. Eichelbaum M, Mineshita S, Ohnhaus EE, Zekorn C (1986) The influence of enzyme induction on polymorphic sparteine oxidation. Br J Clin Pharmacol 22: 49–53

    Google Scholar 

  10. Eichelbaum M, Reetz K-P, Schmidt EK, Zekorn C (1986) The genetic polymorphism of sparteine metabolism. Xenobiotica 16: 465–481

    Google Scholar 

  11. Feuerstein Th, von Reutern GM, Cramer H (1983) Phenytoin-intoxikation bei Abbaustörung, Kasuistik eines Falls mit Kleinhirnatrophie. Nervenarzt 54: 106–109

    Google Scholar 

  12. Gillette JR (1982) The problem of chemically reactive metabolites. Drug Metab Rev 13: 941–961

    Google Scholar 

  13. Gonzales FJ, Kimura S, Nebert DW (1985) Comparison of the flanking regions and introns of the mouse 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 and P3-450 genes. J Biol Chem 260: 5040–5049

    Google Scholar 

  14. Gould BJ, Amoah AGB, Parke DV (1986) Stereoselective pharmacokinetics of perhexiline. Xenobiotica 16: 491–502

    Google Scholar 

  15. Guengerich FP, Distlerath LM, Reilly PEB, Wolff T, Shimada T, Umbenhauer DR, Martin MV (1986a) Human-liver cytochromes P-450 involved in polymorphisms of drug oxidation. Xenobiotica 16: 367–378

    Google Scholar 

  16. Guengerich FP, Martin MV, Beaune PH, Kremers P, Wolff T, Waxman DJ (1986b) Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J Biol Chem 261: 5051–5060

    Google Scholar 

  17. Gurtoo HL, Williams CJ, Gottlieb K, Mulhern AI, Caballes L, Vaught JB, Marinello AJ, Bansal SK (1983) Population distribution of placental benzo(a)pyrene metabolism in smokers. Int J Cancer 31: 29–37

    Google Scholar 

  18. Hildebrand CE, Gonzalez FJ, McBride OW, Nebert DW (1985) Assignment of the human 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-inducible cytochrome P1-450 gene to chromosome 15. Nucleic Acids Res 13: 2009–2016

    Google Scholar 

  19. Hunt PG (1984) In vitro characterization of sparteine monooxygenases present in rat liver. M. Sc. Thesis, University of Toronto, Toronto

    Google Scholar 

  20. Inaba T, Nakano M, Otton SV, Mahon WA, Kalow W (1984) A human cytochrome P-450 characterized by inhibition studies as the sparteine-debrisoquine monooxygenase. Can J Physiol Pharmacol 62: 860–862

    Google Scholar 

  21. Ingelman-Sundberg M (1986) Cytochrome P-450 organization and membrane interactions. In: Ortiz de Montellano PR (ed) Cytochrome P-450; structure, mechanism, and biochemistry. Plenum Press, New York London, pp 119–160

    Google Scholar 

  22. Jaiswal AK, Gonzalez FJ, Nebert DW (1985) Human dioxin-inducible cytochrome P1-450: Complementary DNA and amino acid sequence. Science 228: 80–83

    Google Scholar 

  23. Jaiswal AK, Nebert DW (1986) Two RFLPs associated with the human P1-450 gene linked to the MPI locus on chromosome 15 [HGM8D15S8]. Nucleic Acids Res 14: 4376

    Google Scholar 

  24. Jurima M, Inaba T, Kadar D, Kalow W (1985) Genetic polymorphism of mephenytoin (p(4′)-hydroxylation: Difference between Orientals and Caucasians. Br J Clin Pharmacol 19: 483–487

    Google Scholar 

  25. Jefcoate CR (1986) Cytochrome P-450 enzymes in sterol biosynthesis and metabolism. In: Ortiz de Montellano PR (ed) Cytochrome P-450; structure, mechanism, and biochemistry. Plenum Press, New York London, pp 387–428

    Google Scholar 

  26. Kahn GC, Boobis AR, Brodie MJ, Toverud E-L, Murray S, Davies DS (1985) Phenacetin-O-deethylase: An activity of a cytochrome P-450 showing genetic linkage with that catalysing the 4-hydroxylation of debrisoquine? Br J Clin Pharmacol 20: 67–76

    Google Scholar 

  27. Kalow W (1984) A pharmacologist looks at ecogenetics. In: Omenn GS, Gelboin HV (eds) Genetic variability in responses to chemical exposure. Cold Spring Harbor Laboratory, University of Toronto, Toronto, pp 15–32

    Google Scholar 

  28. Kalow W (1985) Pharmacoanthropology. Ann Biol Clin 43: 519–534

    Google Scholar 

  29. Kalow W (1986a) Genetics of drug transformation. Clin Biochem 19: 76–82

    Google Scholar 

  30. Kalow W (1986b) The genetic defect of mephenytoin hydroxylation. Xenobiotica 16: 379–389

    Google Scholar 

  31. Kalow W, Goedde HW, Agarwal DP (eds) (1986) Ethnic differences in reactions to drugs and xenobiotics. Liss, New York

    Google Scholar 

  32. Kellermann G, Luyten-Kellermann M, Shaw CR (1973) Genetic variation of aryl hydrocarbon hydroxylase in human lymphocytes. Am J Hum Genet 25: 327–331

    Google Scholar 

  33. Kellermann G, Shaw CR, Luyten-Kellerman M (1973) Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. N Engl J Med 289: 934–937

    Google Scholar 

  34. Kleinbloesem CH, van Brummelen P, Faber H, Danhof M, Vermeulen NPE, Breimer DD (1984) Variability in nifedipine pharmacokinetics and dynamics: A new oxidation polymorphism in man. Biochem Pharmacol 33: 3721–3724

    Google Scholar 

  35. Knodell RG, Hall SD, Wilkinson GR, Guengerich FP (1986) In vitro evidence that tolbutamide is hydroxylated by the same human cytochrome P-450 form responsible for mephenytoin 4-hydroxylation. Fed Proc 45: 320

    Google Scholar 

  36. Kouri RE, McKinney CE, Levine AS, Edwards BK, Vesell ES, Nebert DW, McLemore TL (1984) Variations in aryl hydrocarbon hydroxylase activities in mitogen-activated human and nonhuman primate lymphocytes. Toxicol Pathol 12: 44–48

    Google Scholar 

  37. Kouri RE, McLemore T, Jaiswal AK, Nebert DW (1986) In: Kalow W, Goedde HW, Agarwal DP (eds) Ethnic differences in reactions to drugs and xenobiotics. Liss, New York, pp 453–469

    Google Scholar 

  38. Küpfer A, Schmid B, Pfaff G (1986) Pharmacogenetics of dextromethrophan O-demethylation in man. Xenobiotica 16: 421–433

    Google Scholar 

  39. Lambert GH, Kotake AN, Schoeller D (1983) The CO2 breath tests as monitors of the cytochrome P-450 dependent mixed function monooxygenase system. In: MacLeod SM, Okey AB, Spielberg SP (eds) Developmental pharmacology. Liss, New York, pp 119–145

    Google Scholar 

  40. Legraverend C, Karenlampi SO, Bigelow SW, Lalley PA, Kozak CA, Womack JE, Nebert DW (1984) Aryl hydrocarbon hydroxylase induction by benzo[a]anthracene: Regulatory gene localized to the distal portion of mouse chromosome 17. Genetics 107: 447–461

    Google Scholar 

  41. Lennard MS, Tucker GT, Silas JH, Woods HF (1986) Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and antenolol. Xenobiotica 16: 435–447

    Google Scholar 

  42. McAllister CB, Wolfenden HT, Aslanian WS, Woosley RL, Wilkinson GR (1986) Oxidative metabolism of encainide: Polymorphism, pharmacokinetics and clinical considerations. Xenobiotica 16: 483–490

    Google Scholar 

  43. Meyer UA, Gut J, Kronbach T, Skoda C, Meier UT, Catin T (1986) The molecular mechanism of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. Xenobiotica 16: 449–464

    Google Scholar 

  44. Mitchell SC, Waring RH, Haley CS, Idle JR, Smith RL (1984) Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man. Br J Clin Pharmacol 18: 507–521

    Google Scholar 

  45. Montellano de PRO (ed) (1986) Cytochrome P-450; structure, mechanism, and biochemistry. Plenum Press, New York London

    Google Scholar 

  46. Nakamura K, Goto F, Ray WA, McAllister CB, Jacqz E, Wilkinson GR, Branch RA (1985) Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations. Clin Pharmacol Ther 38: 402–408

    Google Scholar 

  47. Nebert DW, Jensen NM (1979) The Ah locus: Genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450 mediated monooxygenases. CRC Crit Rev Biochem 4: 401–438

    Google Scholar 

  48. Newton BW, Benson RC, McCarriston CC (1966) Sparteine sulfate: A potent capricious oxytocic. Am J Obstet Gynecol 94: 234–241

    Google Scholar 

  49. Nordin C, Siwers B, Benitez J, Bertilsson L (1985) Plasma concentrations of nortriptyline and its 10-hydroxy metabolite in depressed patients — relationship to the debrisoquine hydroxylation metabolic ratio. Br J Clin Pharmacol 19: 832–835

    Google Scholar 

  50. Ocraft KP, Muskett JM, Brown S (1985) Localization of the human aryl hydrocarbon hydroxylase gene to the 2q31 2pter region of chromosome 2. Ann Hum Genet 49: 237–239

    Google Scholar 

  51. Okey AB, Roberts EA, Harper PA, Denison MS (1986) Induction of drug-metabolizing enzymes: Mechanisms and consequences. Clin Biochem 19: 132–141

    Google Scholar 

  52. Peterson JA, Prough RA (1986) Cytochrome P-450 reductase and cytochrome b5 in cytochrome P-450 catalysis. In: Ortiz de Montellano PR (ed) Cytochrome P-450; structure, mechanism, and biochemistry, Plenum Press, New York London, pp 89–118

    Google Scholar 

  53. Phillips IR, Shepard EA, Povey S, Davis MB, Kelsey G, Monteiro M, West LF, Cowell J (1985) A cytochrome P-450 gene family mapped to human chromosome 19. Ann Hum Genet 49: 267–274

    Google Scholar 

  54. Plummer S, Boobis AR, Davies DS (1986) Is the activation of aflatoxin B1 catalysed by the same form of cytochrome P-450 as that 4-hydroxylating debrisoquine in rat and/or man? Arch Toxicol 58: 165–170

    Google Scholar 

  55. Pollack MS, Keenan B, Christiansen FT, Cobain TJ, Dawkins RL, Clayton G (1986) The Immunological Detection of a 21-OH deficiency mutation HLA supratype. Am J Hum Genet 38: 688–698

    Google Scholar 

  56. Ruckpaul K, Rein H, Blanck J (1985) Regulationsmechanismen des endoplasmatischen Zytochrom P-450-Systems der Leber. Biomed Biochim Acta 44: 351–379

    Google Scholar 

  57. Schenkman JB, Kupfer D (1982) Hepatic cytochrome P-450 monooxygenase system. International Encyclopedia of Pharmacology and Therapeutics, Pergamon Press

  58. Scott J, Poffenbarger PL (1979) Pharmacogenetics of tolbutamide metabolism in humans. Ddiabetes 28: 41–51

    Google Scholar 

  59. Sjöqvist F, Bertilsson L (1984) Clinical pharmacology of antidepressant drugs: Pharmacogenetics. In: Usdin et al. (eds) Frontiers in biochemical and pharmacological research in depression. Raven Press, New York, pp 359–372

    Google Scholar 

  60. Smith RL (1986) Introduction. Xenobiotica 16: 361–365

    Google Scholar 

  61. Starke DW, Blisard KS, Mieyal JJ (1984) Substrate specificity of the monooxygenase activity of hemoglobin. Mol Pharmacol 25: 467–475

    Google Scholar 

  62. Syvälahti EKG, Lindberg R, Kallio J, De Vocht M (1986) Inhibitory effects of neuroleptics on debrisoquine oxidation in man. Br J Clin Pharmacol 22: 89–92

    Google Scholar 

  63. Tukey RH, Lalley PA, Nebert DW (1984) Localization of cytochrome P1-450 and P3-450 genes to mouse chromosome 9. Proc Natl Acad Sci USA 81: 3163–3166

    Google Scholar 

  64. Uppal R, Sharma PL (1985) Tolbutamide kinetics in normal Indian population. Int J Clin Pharmacol Ther Toxicol 23: 95–96

    Google Scholar 

  65. Vesell ES (1986) Polymorphisms of antipyrine and theophylline metabolism in man: Molecular and clinical implications. Xenobiotica 16: 401–420

    Google Scholar 

  66. Waxman DJ (1986) Rat hepatic cytochrome P-450: Comparative study of multiple isozymic forms. In: Ortiz de Montellano PR (ed) Cytochrome P-450; structure, mechanism, and biochemistry. Plenum Press, New York London, pp 525–540

    Google Scholar 

  67. Whitlock JP Jr (1986) The regulation of cytochrome P-450 gene expression. Ann Rev Pharmacol Toxicol 26: 333–369

    Google Scholar 

  68. Wolf CR (1986) Cytochrome P-450s: Polymorphic multigene families involved in carcinogen activation. Trends Genet 2: 209–214

    Google Scholar 

  69. Wolff de FA, Vermeij P, Ferrari MD, Buruma OJS, Breimer DD (1983) Impairment of phenytoin parahydroxylation as a cause of severe intoxication. Ther Drug Monit 5: 213–215

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Medical Sciences Building, University of Toronto, Toronto, Ontario, Canada

    W. Kalow

Authors
  1. W. Kalow
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalow, W. Genetic variation in the human hepatic cytochrome P-450 system. Eur J Clin Pharmacol 31, 633–641 (1987). https://doi.org/10.1007/BF00541288

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00541288

Key words

Search

Navigation